RecallClass 4 · Caution in use
UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
Read and act on the official notice on GOV.UK
Class 4 recall — Caution in use.
The MHRA uses Class 4 when:
Usually minor defects in packaging or other printed materials.
What all four recall classes mean
| Class | Action | The MHRA's definition |
|---|---|---|
| Class 1 | Immediate action | The defect presents a risk of death or disability. |
| Class 2 | Action within 48 hours | The defect may cause mistreatment or harm to the patient, but it is not life-threatening or serious. |
| Class 3 | Action within 5 days | The defect is unlikely to cause harm to the patient. |
| Class 4 this recall | Caution in use | Usually minor defects in packaging or other printed materials. |
A Class 1 recall usually comes with a National Patient Safety Alert. Source: MHRA, safety communications.
The MHRA's summary
Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint.
Affected batches
As listed by the MHRA, exactly as published. Always check against the GOV.UK notice before acting.
| Batch number | Expiry | Pack size | First distributed |
|---|---|---|---|
| Gabapentin Relonchem 50mg/ml Oral Solution | |||
| 09E1 | 01/10/2026 | 150ML | 12/11/2025 |
| 11E1 | 01/10/2026 | 150ML | 12/11/2025 |
| 12E1 | 01/12/2026 | 150ML | 02/01/2026 |
| 13E1 | 01/12/2026 | 150ML | 02/01/2026 |
| 14E1 | 01/12/2026 | 150ML | 20/01/2026 |
| 19F1 | 01/03/2027 | 150ML | 08/04/2026 |
| 21F1 | 01/04/2027 | 150ML | 12/05/2026 |
MHRA's audience tags: Dispensing GP practices, Pharmacy